Skip to main content

Table 2 Factor analysis for repetitive recurrence

From: Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

   

Univariate analysis

Cox proportional hazards regression analysis

Factors

No. of patients (event)

5-y re-recurrent free survival

P value

Wald Statistic

Regression coefficient (B)

Relative risk (eB)

95 % CI

P value

Age

 < 35 y.o.

66 (18)

0.626

0.332

     

 ≥ 35 y.o.

37 (14)

0.594

 

7.526

1.119

3.062

1.377–6.811

0.006

Gender

 Male

53 (13)

0.656

0.341

     

 Female

50 (19)

0.581

      

Tumor site

 Upper extremity

79 (23)

0.591

0.089

     

 Lower extremity

24 (9)

0.636

      

Tumor location

 Site A

95 (29)

0.616

0.557

     

 Site B

8 (3)

0.625

      

Campanacci

 I

12 (4)

0.550

0.433

     

 II

71 (19)

0.657

      

 III

20 (9)

0.524

      

Initial procedure

 Curettage

98 (30)

0.603

0.785

     

En bloc excision

5 (2)

0.800

      

Status

 Group P

91 (24)

0.682

0.002

     

 Group R

12 (8)

0.563

 

10.831

1.625

5.078

1.929–13.363

< 0.001

Second surgery

 Curettage

84 (29)

0.541

0.034

8.522

2.054

8.522

1.964–30.590

0.004

En-bloc excision

19 (3)

0.872